ATAI
Price
$4.09
Change
-$0.06 (-1.45%)
Updated
Aug 8, 12:38 PM (EDT)
Capitalization
880.4M
10 days until earnings call
RXRX
Price
$5.50
Change
+$0.08 (+1.48%)
Updated
Aug 8, 10:55 AM (EDT)
Capitalization
2.35B
89 days until earnings call
Interact to see
Advertisement

ATAI vs RXRX

Header iconATAI vs RXRX Comparison
Open Charts ATAI vs RXRXBanner chart's image
ATAI Life Sciences
Price$4.09
Change-$0.06 (-1.45%)
Volume$3.46K
Capitalization880.4M
Recursion Pharmaceuticals
Price$5.50
Change+$0.08 (+1.48%)
Volume$11.26K
Capitalization2.35B
ATAI vs RXRX Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. RXRX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a StrongBuy and RXRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ATAI: $4.15 vs. RXRX: $5.41)
Brand notoriety: ATAI and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 72% vs. RXRX: 46%
Market capitalization -- ATAI: $880.4M vs. RXRX: $2.35B
ATAI [@Biotechnology] is valued at $880.4M. RXRX’s [@Biotechnology] market capitalization is $2.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ATAI is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 3 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 4 bearish.
  • RXRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than RXRX.

Price Growth

ATAI (@Biotechnology) experienced а +1.22% price change this week, while RXRX (@Biotechnology) price change was -9.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.06%. For the same industry, the average monthly price growth was +6.45%, and the average quarterly price growth was +12.35%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.35B) has a higher market cap than ATAI($880M). ATAI YTD gains are higher at: 212.030 vs. RXRX (-19.970). ATAI has higher annual earnings (EBITDA): -145.09M vs. RXRX (-524.77M). RXRX has more cash in the bank: 500M vs. ATAI (98.2M). ATAI has less debt than RXRX: ATAI (26.7M) vs RXRX (92.9M). RXRX has higher revenues than ATAI: RXRX (59.8M) vs ATAI (1.86M).
ATAIRXRXATAI / RXRX
Capitalization880M2.35B37%
EBITDA-145.09M-524.77M28%
Gain YTD212.030-19.970-1,062%
P/E RatioN/AN/A-
Revenue1.86M59.8M3%
Total Cash98.2M500M20%
Total Debt26.7M92.9M29%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAIRXRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 18 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAMLX50.24N/A
N/A
Congress Large Cap Growth Retail
UTPIX82.10N/A
N/A
ProFunds Utilities UltraSector Inv
NWGSX28.66N/A
N/A
Nationwide WCM Focused Sm Cp Instl Svc
TCPWX14.00N/A
N/A
Transamerica Capital Growth R6
DFSCX28.55-0.04
-0.14%
DFA US Micro Cap I